Germano Geno J
SEC Form 4 insider trading activity
Germano Geno J has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including DTIL, ENTX, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 29, 2026.
On the most recent filing, Germano Geno J is listed as Director at PRECISION BIOSCIENCES INC. Inside the rolling window, Germano Geno J reported 4 open-market purchases totaling $86K in DTIL and ENTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 20,000 ENTX shares on Feb 10, 2026, worth $30K.
Companies traded
Other insiders at DTIL
Insider Buying
$86K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Germano Geno J made?
Germano Geno J has filed 6 SEC Form 4 filings (6 transaction rows) across 2 companies, including DTIL, ENTX since 2025.
Which companies does Germano Geno J trade?
Germano Geno J has filed SEC Form 4 disclosures for 2 companies, including DTIL, ENTX.
When was Germano Geno J's most recent SEC Form 4 filing?
Germano Geno J's most recent SEC Form 4 filing on Tracefour is dated Sep 29, 2026.
What is Germano Geno J's total buy and sell value in the current window?
Inside the rolling retention window, Germano Geno J bought $86K and sold $0 based on SEC Form 4 filings.
What was Germano Geno J's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20,000 ENTX shares on 2026-02-10, worth $30K, per SEC Form 4 filings.